GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » ROE % Adjusted to Book Value

Zenith Capital (Zenith Capital) ROE % Adjusted to Book Value : 0.00% (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital ROE % Adjusted to Book Value?

Zenith Capital's ROE % for the quarter that ended in . 20 was 0.00%. Zenith Capital's PB Ratio for the quarter that ended in . 20 was N/A. Zenith Capital's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.


Zenith Capital ROE % Adjusted to Book Value Historical Data

The historical data trend for Zenith Capital's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital ROE % Adjusted to Book Value Chart

Zenith Capital Annual Data
Trend
ROE % Adjusted to Book Value

Zenith Capital Quarterly Data
ROE % Adjusted to Book Value

Competitive Comparison of Zenith Capital's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Zenith Capital's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenith Capital's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenith Capital's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zenith Capital's ROE % Adjusted to Book Value falls into.



Zenith Capital ROE % Adjusted to Book Value Calculation

Zenith Capital's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Zenith Capital's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Capital ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Zenith Capital's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenith Capital (Zenith Capital) Business Description

Traded in Other Exchanges
N/A
Address
300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1
Website
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines